SCHEMBL15947779

SCHEMBL15947779

Cc1cccc(/C=C/C=C(\C#N)C(=O)N[C@H](C)c2ccccc2)n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.61
MEN1 O00255 7/20 0.61
STAT3 P40763 1/20 0.60
ALDH1A1 P00352 5/20 0.51
KDM4E B2RXH2 4/20 0.51
MAPT P10636 5/20 0.48
LMNA P02545 4/20 0.48
CYP1A2 P05177 3/20 0.48
CYP3A4 P08684 3/20 0.48
CYP2C19 P33261 3/20 0.48
TP53 P04637 3/20 0.48
MAPK1 P28482 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
RGS12 O14924 2/20 0.48
GMNN O75496 2/20 0.48
CYP2C9 P11712 2/20 0.48
ALOX15 P16050 2/20 0.48
TSHR P16473 2/20 0.48
ALOX12 P18054 2/20 0.48
NFKB1 P19838 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15947782 1.00 KMT2A (0.61) KMT2AMEN1STAT3ALDH1A1KDM4E
Mol-4239 SCHEMBL1316581 0.88 STAT3 (0.77) KMT2AMEN1STAT3ALDH1A1KDM4E
SCHEMBL841260 0.88 KMT2A (0.60) KMT2AMEN1STAT3ALDH1A1KDM4E
SCHEMBL1573453 0.88 KMT2A (0.60) KMT2AMEN1STAT3ALDH1A1KDM4E
SCHEMBL841782 0.88 KMT2A (0.60) KMT2AMEN1STAT3ALDH1A1KDM4E
SCHEMBL841259 0.88 KMT2A (0.60) KMT2AMEN1STAT3ALDH1A1KDM4E
Mol-4239 SCHEMBL862248 0.88 STAT3 (0.77) KMT2AMEN1STAT3ALDH1A1KDM4E
Mol-4239 SCHEMBL1318844 0.88 STAT3 (0.77) KMT2AMEN1STAT3ALDH1A1KDM4E
SCHEMBL841781 0.88 KMT2A (0.60) KMT2AMEN1STAT3ALDH1A1KDM4E
Mol-4239 SCHEMBL29818004 0.88 STAT3 (0.77) KMT2AMEN1STAT3ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140228414-A1 NOVEL INHIBITORS OF PROLIFERATION AND ACTIVATION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STATS) BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140228414-A1 NOVEL INHIBITORS OF PROLIFERATION AND ACTIVATION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STATS) STAT5A, STAT3, STAT5B KMT2A 1746/4885MEN1 4004/4885STAT3 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.